Drug Shortage Report for CYSTO-CONRAY II

Last updated on 2018-10-23 History
Report ID 8941
Drug Identification Number 00397466
Brand name CYSTO-CONRAY II
Common or Proper name Iothalamate Meglumine Injection USP 17.2%
Company Name LIEBEL-FLARSHEIM COMPANY LLC
Market Status MARKETED
Active Ingredient(s) IOTHALAMATE MEGLUMINE
Strength(s) 172MG
Dosage form(s) SOLUTION
Route of administration URETHRAL
Packaging size 250 mL, 500 mL
ATC code V08AA
ATC description X-RAY CONTRAST MEDIA, IODINATED
Reason for shortage Shortage of an active ingredient.
Anticipated start date
Actual start date 2017-05-03
Estimated end date 2018-10-22
Actual end date 2018-10-22
Shortage status Resolved
Updated date 2018-10-23
Company comments Shipment is in transit. For more information, please contact Methapharm Inc. at 1-800-287-7686, sales@methapharm.com, or by fax at 1-519-751-9149.
Health Canada comments
Tier 3 Status No
Contact Address 8800 DURANT RD.
RALEIGH, NORTH CAROLINA
UNITED STATES 27616
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v16 2018-10-23 English Compare
v15 2018-10-22 French Compare
v14 2018-10-22 English Compare
v13 2018-10-17 French Compare
v12 2018-10-17 English Compare
v11 2018-10-11 French Compare
v10 2018-10-11 English Compare
v9 2018-09-27 French Compare
v8 2018-09-27 English Compare
v7 2018-08-17 French Compare
v6 2018-08-17 English Compare
v5 2018-04-18 French Compare
v4 2018-04-18 English Compare
v3 2017-05-04 French Compare
v2 2017-05-04 English Compare
v1 2017-05-04 English Compare

Showing 1 to 16 of 16